1.0
Sep 19, 2017
Recommend
CEO approval
Business Outlook
Pros
Benefits are competitive, but at the expense of pay, raises, and bonuses--all of which compare poorly to industry norm's (try bottom 25%)
Cons
Sanofi-Genzyme is a worst case, plodding big-pharma mess. The thought that Genzyme could be the kernel around which a biotech leader could be built is laughable—by industry standards Genzyme is ancient history. More troubling is a low performing culture, no incentives, no motivation, and truly horrible management. There are forms and processes galore but no real adherence to the processes, nor to ethical standards— even common sense and common decency have left the building. The only thing good about employment here is it affords you time to actively search for another job.